4-BROMO-2'-METHOXYBIPHENYL
- $772 - $1943
- Product name: 4-BROMO-2'-METHOXYBIPHENYL
- CAS: 169691-87-6
- MF: C13H11BrO
- MW: 263.13
- EINECS:
- MDL Number:MFCD07775604
- Synonyms:4-BROMO-2'-METHOXYBIPHENYL;1,1'-Biphenyl, 4'-bromo-2-methoxy-;4'-bromo-2-methoxy-1,1'-biphenyl
5 prices
Selected condition:
Brand
- A1 Biochem Labs
- Crysdot
- Matrix Scientific
- Rieke Metals
Package
- 1g
- 5G
- ManufacturerA1 Biochem Labs
- Product number6571719
- Product description4-Bromo-2'-methoxybiphenyl 95%
- Packaging5G
- Price$1050
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12134558
- Product description4'-Bromo-2-methoxy-1,1'-biphenyl 97%
- Packaging1g
- Price$772
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number182635
- Product description4-Bromo-2'-methoxybiphenyl 95%
- Packaging5g
- Price$1733
- Updated2021-12-16
- Buy
- ManufacturerRieke Metals
- Product numberNV01606
- Product description4-BROMO-2'-METHOXYBIPHENYL
- Packaging5g
- Price$1943
- Updated2021-12-16
- Buy
- ManufacturerRieke Metals
- Product numberNV01606
- Product description4-BROMO-2'-METHOXYBIPHENYL
- Packaging1g
- Price$809
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
A1 Biochem Labs | 6571719 | 4-Bromo-2'-methoxybiphenyl 95% | 5G | $1050 | 2021-12-16 | Buy |
Crysdot | CD12134558 | 4'-Bromo-2-methoxy-1,1'-biphenyl 97% | 1g | $772 | 2021-12-16 | Buy |
Matrix Scientific | 182635 | 4-Bromo-2'-methoxybiphenyl 95% | 5g | $1733 | 2021-12-16 | Buy |
Rieke Metals | NV01606 | 4-BROMO-2'-METHOXYBIPHENYL | 5g | $1943 | 2021-12-16 | Buy |
Rieke Metals | NV01606 | 4-BROMO-2'-METHOXYBIPHENYL | 1g | $809 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|